XML 38 R30.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stockholders' Equity (Tables)
 3 Months Ended
Dec. 31, 2024
Stockholders' Equity Note [Abstract]  
Schedule of stockholders' equity

The changes in stockholders’ equity for the prior year comparable period are as follows:

 

 

 

 

 

 

Additional

 

 

 

 

 

Accumulated
Other

 

 

 

 

 

 

Common Stock

 

Paid-in

 

Treasury Stock

 

Comprehensive

 

Retained

 

 

 

 

Shares

 

Amount

 

Capital

 

Shares

 

Amount

 

Loss

 

Earnings

 

Total

 

Balance at September 30, 2023

 

36,142,345

 

$

36

 

$

265,945

 

 

(5,433,045

)

$

(84,031

)

$

(10,458

)

$

(9,958

)

$

161,533

 

Net income

 

—

 

 

—

 

 

—

 

 

—

 

 

—

 

 

—

 

 

1,907

 

 

1,907

 

Exercise of stock options, grants of restricted stock awards, and vesting of restricted stock units

 

59,471

 

 

—

 

 

127

 

 

—

 

 

—

 

 

—

 

 

—

 

 

127

 

Taxes paid associated with net settlement of stock compensation awards

 

(12,058

)

 

—

 

 

(224

)

 

—

 

 

—

 

 

—

 

 

—

 

 

(224

)

Common stock repurchased

 

—

 

 

—

 

 

—

 

 

(68,692

)

 

(1,171

)

 

—

 

 

—

 

 

(1,171

)

Stock compensation expense

 

—

 

 

—

 

 

2,249

 

 

—

 

 

—

 

 

—

 

 

—

 

 

2,249

 

Foreign currency translation and other

 

—

 

 

—

 

 

—

 

 

—

 

 

—

 

 

958

 

 

—

 

 

958

 

Balance at December 31, 2023

 

36,189,758

 

$

36

 

$

268,096

 

 

(5,501,737

)

$

(85,202

)

$

(9,500

)

$

(8,051

)

$

165,379

 
Summary of share-based compensation expense

The table below presents the components of share-based compensation expense (in thousands):

 

 

 

Three Months Ended December 31,

 

 

 

2024

 

 

2023

 

Equity-classified awards:

 

 

 

 

 

 

Stock options

 

$

659

 

 

$

500

 

RSUs & RSAs

 

 

2,772

 

 

 

1,749

 

Total Equity-classified award

 

 

3,431

 

 

 

2,249

 

Liability-classified awards:

 

 

 

 

 

 

SARs

 

 

—

 

 

 

—

 

Total stock compensation expense:

 

$

3,431

 

 

$

2,249

 

The table below presents the components of share-based compensation expense by line-item within our Condensed Consolidated Statements of Operations (in thousands):

 

 

 

Three Months Ended December 31,

 

 

 

2024

 

 

2023

 

Stock-compensation expense by function

 

 

 

 

 

 

Technology and operations

 

$

551

 

 

$

330

 

Sales and marketing

 

 

1,021

 

 

 

638

 

General and administrative

 

 

1,859

 

 

 

1,281

 

Total stock compensation expense:

 

$

3,431

 

 

$

2,249

 
Summary of stock options and restricted stock granted

The following table presents stock option and RSUs & RSAs grant activity:

 



 

Three Months Ended December 31, 2024

 

Stock Options granted:

 



 

Options containing only service conditions:

 

 

125,000

 

Weighted average exercise price

 

$

22.55

 

Weighted average grant date fair value

 

$

10.86

 



 



 

Options containing performance conditions:

 

 

125,000

 

Weighted average exercise price

 

$

22.55

 

Weighted average grant date fair value

 

$

10.86

 



 



 

RSUs & RSAs granted:

 



 

RSUs & RSAs containing only service conditions:

 

 

304,519

 

Weighted average grant date fair value

 

$

23.55

 



 



 

RSUs & RSAs containing performance conditions:

 

 

304,521

 

Weighted average grant date fair value

 

$

23.55

 
Summary of fair value assumptions, stock options

The range of assumptions used to determine the fair value of stock options using the Black-Scholes option-pricing model during the three months ended December 31, 2024, were as follows:

 

 

 

Three Months Ended

 

 

 

December 31, 2024

 

Dividend yield

 

 

—

 

Expected volatility

 

56.09% - 57.96%

 

Risk-free interest rate

 

4.10% - 4.10%

 

Expected term

 

4.4 - 5.0 years